Diagnostic Healthcare (DHC) is a provider of diagnostic imaging services in the United Kingdom, offering a wide range of services to both public and private customers. Founded in 2002 and headquartered in Manchester, DHC has established itself as a key player in the diagnostic imaging sector, with a strong reputation for quality, efficiency, and innovation.DHC generates revenue by providing a comprehensive range of diagnostic imaging services, including MRI, CT, X-ray, Ultrasound, Mammography, Bone Densitometry, Nuclear Medicine, and PET/CT. The company operates a network of state-of-the-art diagnostic imaging centers across the UK, serving both NHS and private patients.In December 2020, G Square Healthcare Private Equity LLP, a European healthcare private equity investor, acquired a majority stake in DHC. This investment aimed to support DHC's growth strategy and expand its presence in the UK diagnostic imaging market. G Square Healthcare Private Equity LLP is known for its focus on mid-market healthcare companies with high growth potential and has a proven track record of successful investments in the sector.Under G Square's ownership, DHC has continued to invest in its infrastructure, technology, and personnel to enhance its service offerings and expand its geographical reach. In 2021, DHC acquired Medica Reporting, a provider of teleradiology services in the UK, further strengthening its position in the diagnostic imaging market.DHC aims to further expand its network, enhance its service offerings, and improve patient outcomes through innovative diagnostic solutions.